This map shows the geographic impact of Simoons Ml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simoons Ml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simoons Ml more than expected).
This network shows the impact of papers produced by Simoons Ml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simoons Ml. The network helps show where Simoons Ml may publish in the future.
Co-authorship network of co-authors of Simoons Ml
This figure shows the co-authorship network connecting the top 25 collaborators of Simoons Ml.
A scholar is included among the top collaborators of Simoons Ml based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Simoons Ml. Simoons Ml is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Hasdai, David, Eric J. Topol, Rakhi Kilaru, et al.. (2001). Frequency, Patient Characteristics, and Outcomes of Mild to Moderate Heart Failure Complicating ST-Segment Elevation Acute Myocardial Infarction: Lessons from Four International Fibrinolytic Therapy Trials. Circulation. 104(17).1 indexed citations
4.
Boersma, Eric, et al.. (2001). Acute Coronary Syndrome Patients Benefit from Platelet Glycoprotein IIb/IIIa Inhibition as Part of an Initially Medical Treatment Strategy: Results of a Meta-Analysis of Phase III Randomized Trials. Circulation. 104(17).
5.
Bowman, Lee, et al.. (1998). Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Evaluation of 7E3 for the Prevention of Ischemic Complications.. PubMed. 19 Suppl D. D59–66.13 indexed citations
6.
Ml, Simoons, et al.. (1998). EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease.. PubMed. 19 Suppl J. J56–60.8 indexed citations
7.
Ml, Simoons, et al.. (1995). The Survival Advantage of Early Complete Reperfusion (TIMI Grade 3) After Infarction Doubles Between 30 Days and 2 Years. Circulation. 92(8).2 indexed citations
8.
Ml, Simoons, et al.. (1994). Compensatory Hyperkinesis : The Ejection Fraction 'Equalizer' after MI. Circulation. 90(4).
9.
White, HD, et al.. (1994). Functional Status Following Stroke After Thrombolytic Therapy - Results From the GUSTO Trial. Journal of the American College of Cardiology. 23.1 indexed citations
10.
Lenderink, Timo, et al.. (1993). Risk assessment and longterm survival after thrombolytic therapy. European Heart Journal. 14. 107–107.1 indexed citations
11.
Simes, John, et al.. (1993). Mortality reduction with accelerated tissue plasminogen activator is explained by early coronary patency. Circulation. 88.2 indexed citations
12.
Lenderink, Timo, et al.. (1993). Complete coronary perfusion (TIMI flow 3) improves prognosis after myocardial infarction but not incomplete (TIMI 2) perfusion. European Heart Journal. 14. 444–444.2 indexed citations
13.
Cobbaert, Christa M., et al.. (1993). Extra myoglobin peaks corroborate the diagnosis of stuttering infarction. Circulation. 88.1 indexed citations
Ml, Simoons, et al.. (1993). Intracranial hemorrhage after thrombolytic therapy. A perspective.. PubMed. 82 Suppl 2. 153–6.5 indexed citations
16.
Ml, Simoons, et al.. (1993). Coronary artery disease after heart transplantation: timing of coronary arteriography.. PubMed. 12(1 Pt 1). 89–99.28 indexed citations
17.
Werf, Frans Van de, et al.. (1992). Ridogrel as adjunct to thrombolysis in acute myocardial infarction. Circulation. 86.2 indexed citations
18.
Ml, Simoons, et al.. (1990). [Earlier treatment of acute myocardial infarction with administration of alteplase (rt-PA) before hospitalization].. PubMed. 134(50). 2434–8.2 indexed citations
19.
Werf, Frans Van de, et al.. (1988). Intravenous rt-PA for acute myocardial infarction: which patients benefit most?. Circulation. 78.1 indexed citations
20.
Fioretti, P., et al.. (1987). Improved prognosis during and after myocardial infarction: a plea for an integrated and stratified approach.. PubMed. 2(6). 345–52.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.